{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:20:57Z","timestamp":1783772457351,"version":"3.55.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MUC1 is a transmembrane mucin that can promote cancer progression, and its upregulation correlates with a worse prognosis in colon cancer. We examined the effects of overexpression of MUC1 in colon cancer cells, finding that it induced epithelial to mesenchymal transition (EMT), including enhanced migration and invasion, and increased Akt phosphorylation. When the clones were treated with the aspirin metabolite salicylate, Akt phosphorylation was decreased and EMT inhibited. As the salicylate motif is necessary for the activity of the lysine acetyltransferase (KAT) inhibitor anacardic acid, we hypothesized these effects were associated with the inhibition of KAT activity. This was supported by anacardic acid treatment producing the same effect on EMT. <jats:italic>In vitro<\/jats:italic> KAT assays confirmed that salicylate directly inhibited PCAF\/Kat2b, Tip60\/Kat5 and hMOF\/Kat8, and this inhibition was likely involved in the reversal of EMT in the metastatic prostate cancer cell line PC-3. Salicylate treatment also inhibited EMT induced by cytokines, illustrating the general effect it had on this process. The inhibition of both EMT and KATs by salicylate presents a little explored activity that could explain some of the anti-cancer effects of aspirin.<\/jats:p>","DOI":"10.1038\/s41598-017-06149-4","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T14:11:06Z","timestamp":1499782266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The aspirin metabolite salicylate inhibits lysine acetyltransferases and MUC1 induced epithelial to mesenchymal transition"],"prefix":"10.1038","volume":"7","author":[{"given":"Harvey R.","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Lind\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"key":"6149_CR1","doi-asserted-by":"crossref","unstructured":"Lind\u00e9n, S. K. et al. MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS pathogens \n                           5, e1000617, doi:19816567 (2009).","DOI":"10.1371\/journal.ppat.1000617"},{"key":"6149_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1042\/BJ20140617","volume":"465","author":"D Banerjee","year":"2015","unstructured":"Banerjee, D. et al. Epithelial MUC1 promotes cell migration, reduces apoptosis and affects levels of mucosal modulators during acetylsalicylic acid (aspirin)-induced gastropathy. The Biochemical journal \n                           465, 423\u2013431, doi:10.1042\/BJ20140617 (2015).","journal-title":"The Biochemical journal"},{"key":"6149_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molmed.2014.02.007","volume":"20","author":"S Nath","year":"2014","unstructured":"Nath, S. & Mukherjee, P. MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends in molecular medicine \n                           20, 332\u2013342, doi:10.1016\/j.molmed.2014.02.007 (2014).","journal-title":"Trends in molecular medicine"},{"key":"6149_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/MCG.0b013e3182688e73","volume":"47","author":"D Boltin","year":"2013","unstructured":"Boltin, D., Perets, T. T., Vilkin, A. & Niv, Y. Mucin function in inflammatory bowel disease: an update. Journal of clinical gastroenterology \n                           47, 106\u2013111, doi:10.1097\/MCG.0b013e3182688e73 (2013).","journal-title":"Journal of clinical gastroenterology"},{"key":"6149_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00281-012-0352-6","volume":"35","author":"SI Grivennikov","year":"2013","unstructured":"Grivennikov, S. I. Inflammation and colorectal cancer: colitis-associated neoplasia. Seminars in immunopathology \n                           35, 229\u2013244, doi:10.1007\/s00281-012-0352-6 (2013).","journal-title":"Seminars in immunopathology"},{"key":"6149_CR6","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1038\/sj.onc.1207713","volume":"23","author":"JA Schroeder","year":"2004","unstructured":"Schroeder, J. A. et al. MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation. Oncogene \n                           23, 5739\u20135747, doi:10.1038\/sj.onc.1207713 (2004).","journal-title":"Oncogene"},{"key":"6149_CR7","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.4049\/jimmunol.181.5.3116","volume":"181","author":"TL Tinder","year":"2008","unstructured":"Tinder, T. L. et al. MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. Journal of immunology \n                           181, 3116\u20133125 (2008).","journal-title":"Journal of immunology"},{"key":"6149_CR8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.4049\/jimmunol.179.2.735","volume":"179","author":"PL Beatty","year":"2007","unstructured":"Beatty, P. L., Plevy, S. E., Sepulveda, A. R. & Finn, O. J. Cutting edge: transgenic expression of human MUC1 in IL-10\u2212\/\u2212 mice accelerates inflammatory bowel disease and progression to colon cancer. Journal of immunology \n                           179, 735\u2013739 (2007).","journal-title":"Journal of immunology"},{"key":"6149_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0016-5085(94)90592-4","volume":"106","author":"S Nakamori","year":"1994","unstructured":"Nakamori, S., Ota, D. M., Cleary, K. R., Shirotani, K. & Irimura, T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology \n                           106, 353\u2013361 (1994).","journal-title":"Gastroenterology"},{"key":"6149_CR10","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1158\/1078-0432.CCR-03-0163","volume":"10","author":"SE Baldus","year":"2004","unstructured":"Baldus, S. E. et al. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clinical cancer research: an official journal of the American Association for Cancer Research \n                           10, 2790\u20132796 (2004).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"6149_CR11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. The Journal of clinical investigation \n                           119, 1420\u20131428, doi:10.1172\/JCI39104 (2009).","journal-title":"The Journal of clinical investigation"},{"key":"6149_CR12","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/onc.2010.526","volume":"30","author":"LD Roy","year":"2011","unstructured":"Roy, L. D. et al. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene \n                           30, 1449\u20131459, doi:10.1038\/onc.2010.526 (2011).","journal-title":"Oncogene"},{"key":"6149_CR13","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/onc.2011.410","volume":"31","author":"JK Woo","year":"2012","unstructured":"Woo, J. K. et al. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway. Oncogene \n                           31, 2187\u20132198, doi:10.1038\/onc.2011.410 (2012).","journal-title":"Oncogene"},{"key":"6149_CR14","doi-asserted-by":"publisher","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","volume":"24","author":"L Larue","year":"2005","unstructured":"Larue, L. & Bellacosa, A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3\u2019 kinase\/AKT pathways. Oncogene \n                           24, 7443\u20137454, doi:10.1038\/sj.onc.1209091 (2005).","journal-title":"Oncogene"},{"key":"6149_CR15","doi-asserted-by":"publisher","first-page":"8893","DOI":"10.18632\/oncotarget.2360","volume":"5","author":"A Kharbanda","year":"2014","unstructured":"Kharbanda, A. et al. MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells. Oncotarget \n                           5, 8893\u20138905 (2014).","journal-title":"Oncotarget"},{"key":"6149_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3330","volume":"13","author":"MS Song","year":"2012","unstructured":"Song, M. S., Salmena, L. & Pandolfi, P. P. The functions and regulation of the PTEN tumour suppressor. Nature reviews. Molecular cell biology \n                           13, 283\u2013296, doi:10.1038\/nrm3330 (2012).","journal-title":"Nature reviews. Molecular cell biology"},{"key":"6149_CR17","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/ph5121346","volume":"5","author":"M Dovizio","year":"2012","unstructured":"Dovizio, M., Tacconelli, S., Sostres, C., Ricciotti, E. & Patrignani, P. Mechanistic and pharmacological issues of aspirin as an anticancer agent. Pharmaceuticals \n                           5, 1346\u20131371, doi:10.3390\/ph5121346 (2012).","journal-title":"Pharmaceuticals"},{"key":"6149_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejmech.2011.11.001","volume":"47","author":"M Ghizzoni","year":"2012","unstructured":"Ghizzoni, M. et al. 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site. European journal of medicinal chemistry \n                           47, 337\u2013344, doi:10.1016\/j.ejmech.2011.11.001 (2012).","journal-title":"European journal of medicinal chemistry"},{"key":"6149_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.tem.2013.06.002","volume":"24","author":"GR Steinberg","year":"2013","unstructured":"Steinberg, G. R., Dandapani, M. & Hardie, D. G. AMPK: mediating the metabolic effects of salicylate-based drugs? Trends in endocrinology and metabolism: TEM \n                           24, 481\u2013487, doi:10.1016\/j.tem.2013.06.002 (2013).","journal-title":"Trends in endocrinology and metabolism: TEM"},{"key":"6149_CR20","first-page":"6334","volume":"50","author":"T Lesuffleur","year":"1990","unstructured":"Lesuffleur, T., Barbat, A., Dussaulx, E. & Zweibaum, A. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer research \n                           50, 6334\u20136343 (1990).","journal-title":"Cancer research"},{"key":"6149_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2165\/00003088-198510020-00004","volume":"10","author":"CJ Needs","year":"1985","unstructured":"Needs, C. J. & Brooks, P. M. Clinical pharmacokinetics of the salicylates. Clinical pharmacokinetics \n                           10, 164\u2013177, doi:10.2165\/00003088-198510020-00004 (1985).","journal-title":"Clinical pharmacokinetics"},{"key":"6149_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/onc.2010.421","volume":"30","author":"QS Zhu","year":"2011","unstructured":"Zhu, Q. S. et al. Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene \n                           30, 457\u2013470, doi:10.1038\/onc.2010.421 (2011).","journal-title":"Oncogene"},{"key":"6149_CR23","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1096\/fj.09-151639","volume":"24","author":"MG Mendez","year":"2010","unstructured":"Mendez, M. G., Kojima, S. & Goldman, R. D. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB journal: official publication of the Federation of American Societies for Experimental Biology \n                           24, 1838\u20131851, doi:10.1096\/fj.09-151639 (2010).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"6149_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell \n                           149, 274\u2013293, doi:10.1016\/j.cell.2012.03.017 (2012).","journal-title":"Cell"},{"key":"6149_CR25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/436792a","volume":"436","author":"DW Parsons","year":"2005","unstructured":"Parsons, D. W. et al. Colorectal cancer: mutations in a signalling pathway. Nature \n                           436, 792, doi:10.1038\/436792a (2005).","journal-title":"Nature"},{"key":"6149_CR26","doi-asserted-by":"publisher","unstructured":"Din, F. V. et al. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology \n                           142, 1504-515 e1503, doi:10.1053\/j.gastro.2012.02.050 (2012).","DOI":"10.1053\/j.gastro.2012.02.050"},{"key":"6149_CR27","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1126\/science.1215327","volume":"336","author":"SA Hawley","year":"2012","unstructured":"Hawley, S. A. et al. The ancient drug salicylate directly activates AMP-activated protein kinase. Science \n                           336, 918\u2013922, doi:10.1126\/science.1215327 (2012).","journal-title":"Science"},{"key":"6149_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1476-4598-9-162","volume":"9","author":"DS Yee","year":"2010","unstructured":"Yee, D. S. et al. The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition. Molecular cancer \n                           9, 162, doi:10.1186\/1476-4598-9-162 (2010).","journal-title":"Molecular cancer"},{"key":"6149_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejso.2010.12.003","volume":"37","author":"CP Hsu","year":"2011","unstructured":"Hsu, C. P. et al. Clinical significance of tumor suppressor PTEN in colorectal carcinoma. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology \n                           37, 140\u2013147, doi:10.1016\/j.ejso.2010.12.003 (2011).","journal-title":"European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"6149_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ccr.2014.01.028","volume":"25","author":"J Shi","year":"2014","unstructured":"Shi, J. et al. Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer. Cancer cell \n                           25, 210\u2013225, doi:10.1016\/j.ccr.2014.01.028 (2014).","journal-title":"Cancer cell"},{"key":"6149_CR31","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1158\/0008-5472.CAN-04-3785","volume":"65","author":"WK Kwok","year":"2005","unstructured":"Kwok, W. K. et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer research \n                           65, 5153\u20135162, doi:10.1158\/0008-5472.CAN-04-3785 (2005).","journal-title":"Cancer research"},{"key":"6149_CR32","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3892\/ijo.2014.2266","volume":"44","author":"L Cao","year":"2014","unstructured":"Cao, L. et al. Correlation of low expression of hMOF with clinicopathological features of colorectal carcinoma, gastric cancer and renal cell carcinoma. International journal of oncology \n                           44, 1207\u20131214, doi:10.3892\/ijo.2014.2266 (2014).","journal-title":"International journal of oncology"},{"key":"6149_CR33","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.1128\/MCB.25.15.6798-6810.2005","volume":"25","author":"M Taipale","year":"2005","unstructured":"Taipale, M. et al. hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Molecular and cellular biology \n                           25, 6798\u20136810, doi:10.1128\/MCB.25.15.6798-6810.2005 (2005).","journal-title":"Molecular and cellular biology"},{"key":"6149_CR34","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/sj.onc.1210915","volume":"27","author":"S Uttamsingh","year":"2008","unstructured":"Uttamsingh, S. et al. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene \n                           27, 2626\u20132634, doi:10.1038\/sj.onc.1210915 (2008).","journal-title":"Oncogene"},{"key":"6149_CR35","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1200\/JCO.2013.52.0080","volume":"31","author":"CS Fuchs","year":"2013","unstructured":"Fuchs, C. S. & Ogino, S. Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex! Journal of clinical oncology: official journal of the American Society of Clinical Oncology \n                           31, 4358\u20134361, doi:10.1200\/JCO.2013.52.0080 (2013).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"6149_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10735-008-9164-3","volume":"39","author":"X Chen","year":"2008","unstructured":"Chen, X., Halberg, R. B., Burch, R. P. & Dove, W. F. Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition. Journal of molecular histology \n                           39, 283\u2013294, doi:10.1007\/s10735-008-9164-3 (2008).","journal-title":"Journal of molecular histology"},{"key":"6149_CR37","doi-asserted-by":"publisher","first-page":"e46665","DOI":"10.1371\/journal.pone.0046665","volume":"7","author":"F Kroepil","year":"2012","unstructured":"Kroepil, F. et al. Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas. PloS one \n                           7, e46665, doi:10.1371\/journal.pone.0046665 (2012).","journal-title":"PloS one"},{"key":"6149_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/carcin\/23.1.201","volume":"23","author":"HK Roy","year":"2002","unstructured":"Roy, H. K. et al. AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis \n                           23, 201\u2013205 (2002).","journal-title":"Carcinogenesis"},{"key":"6149_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/carcin\/bgr306","volume":"33","author":"J Munding","year":"2012","unstructured":"Munding, J. et al. The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the beta-catenin signaling pathway. Carcinogenesis \n                           33, 637\u2013643, doi:10.1093\/carcin\/bgr306 (2012).","journal-title":"Carcinogenesis"},{"key":"6149_CR40","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/carcin\/bgl220","volume":"28","author":"LA Stark","year":"2007","unstructured":"Stark, L. A. et al. Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer. Carcinogenesis \n                           28, 968\u2013976, doi:10.1093\/carcin\/bgl220 (2007).","journal-title":"Carcinogenesis"},{"key":"6149_CR41","doi-asserted-by":"publisher","unstructured":"Shirakawa, K. et al. Salicylate, diflunisal and their metabolites inhibit CBP\/p300 and exhibit anticancer activity. Elife \n                           5, doi:10.7554\/eLife.11156 (2016).","DOI":"10.7554\/eLife.11156"},{"key":"6149_CR42","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell, P. M. et al. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet \n                           379, 1591\u20131601, doi:10.1016\/S0140-6736(12)60209-8 (2012).","journal-title":"Lancet"},{"key":"6149_CR43","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","volume":"369","author":"E Flossmann","year":"2007","unstructured":"Flossmann, E., Rothwell, P. M., British Doctors Aspirin, T. & the, U. K. T. I. A. A. T. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet \n                           369, 1603\u20131613, doi:10.1016\/S0140-6736(07)60747-8 (2007).","journal-title":"Lancet"},{"key":"6149_CR44","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","volume":"378","author":"J Burn","year":"2011","unstructured":"Burn, J. et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet \n                           378, 2081\u20132087, doi:10.1016\/S0140-6736(11)61049-0 (2011).","journal-title":"Lancet"},{"key":"6149_CR45","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","volume":"367","author":"X Liao","year":"2012","unstructured":"Liao, X. et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. The New England journal of medicine \n                           367, 1596\u20131606, doi:10.1056\/NEJMoa1207756 (2012).","journal-title":"The New England journal of medicine"},{"key":"6149_CR46","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1200\/JCO.2013.50.0322","volume":"31","author":"E Domingo","year":"2013","unstructured":"Domingo, E. et al. Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology \n                           31, 4297\u20134305, doi:10.1200\/JCO.2013.50.0322 (2013).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"6149_CR47","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1128\/MCB.25.12.5292-5305.2005","volume":"25","author":"A Gupta","year":"2005","unstructured":"Gupta, A. et al. Involvement of human MOF in ATM function. Molecular and cellular biology \n                           25, 5292\u20135305, doi:10.1128\/MCB.25.12.5292-5305.2005 (2005).","journal-title":"Molecular and cellular biology"},{"key":"6149_CR48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0092-8674(00)00051-9","volume":"102","author":"T Ikura","year":"2000","unstructured":"Ikura, T. et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell \n                           102, 463\u2013473 (2000).","journal-title":"Cell"},{"key":"6149_CR49","first-page":"3953","volume":"29","author":"K Sakuraba","year":"2009","unstructured":"Sakuraba, K. et al. Down-regulation of Tip60 gene as a potential marker for the malignancy of colorectal cancer. Anticancer research \n                           29, 3953\u20133955 (2009).","journal-title":"Anticancer research"},{"key":"6149_CR50","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1016\/j.febslet.2006.06.092","volume":"580","author":"Y Sun","year":"2006","unstructured":"Sun, Y., Jiang, X., Chen, S. & Price, B. D. Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS letters \n                           580, 4353\u20134356, doi:10.1016\/j.febslet.2006.06.092 (2006).","journal-title":"FEBS letters"},{"key":"6149_CR51","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1111\/j.1349-7006.2011.01971.x","volume":"102","author":"K Yamaguchi","year":"2011","unstructured":"Yamaguchi, K. et al. MRG-binding protein contributes to colorectal cancer development. Cancer science \n                           102, 1486\u20131492, doi:10.1111\/j.1349-7006.2011.01971.x (2011).","journal-title":"Cancer science"},{"key":"6149_CR52","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1101\/gad.1385806","volume":"20","author":"J Sierra","year":"2006","unstructured":"Sierra, J., Yoshida, T., Joazeiro, C. A. & Jones, K. A. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes & development \n                           20, 586\u2013600, doi:10.1101\/gad.1385806 (2006).","journal-title":"Genes & development"},{"key":"6149_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1091\/mbc.E08-08-0792","volume":"20","author":"X Ge","year":"2009","unstructured":"Ge, X., Jin, Q., Zhang, F., Yan, T. & Zhai, Q. PCAF acetylates {beta}-catenin and improves its stability. Molecular biology of the cell \n                           20, 419\u2013427, doi:10.1091\/mbc.E08-08-0792 (2009).","journal-title":"Molecular biology of the cell"},{"key":"6149_CR54","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/43466","volume":"401","author":"ON Ozes","year":"1999","unstructured":"Ozes, O. N. et al. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature \n                           401, 82\u201385, doi:10.1038\/43466 (1999).","journal-title":"Nature"},{"key":"6149_CR55","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/jcb.21695","volume":"104","author":"C Min","year":"2008","unstructured":"Min, C., Eddy, S. F., Sherr, D. H. & Sonenshein, G. E. NF-kappaB and epithelial to mesenchymal transition of cancer. Journal of cellular biochemistry \n                           104, 733\u2013744, doi:10.1002\/jcb.21695 (2008).","journal-title":"Journal of cellular biochemistry"},{"key":"6149_CR56","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.onc.1209808","volume":"26","author":"HL Chua","year":"2007","unstructured":"Chua, H. L. et al. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene \n                           26, 711\u2013724, doi:10.1038\/sj.onc.1209808 (2007).","journal-title":"Oncogene"},{"key":"6149_CR57","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1182\/blood-2007-10-117994","volume":"111","author":"B Sung","year":"2008","unstructured":"Sung, B. et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood \n                           111, 4880\u20134891, doi:10.1182\/blood-2007-10-117994 (2008).","journal-title":"Blood"},{"key":"6149_CR58","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1002\/ijc.24748","volume":"125","author":"D Bai","year":"2009","unstructured":"Bai, D., Ueno, L. & Vogt, P. K. Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt. International journal of cancer. Journal international du cancer \n                           125, 2863\u20132870, doi:10.1002\/ijc.24748 (2009).","journal-title":"International journal of cancer. Journal international du cancer"},{"key":"6149_CR59","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1158\/0008-5472.CAN-12-3876","volume":"73","author":"J Liang","year":"2013","unstructured":"Liang, J. & Mills, G. B. AMPK: a contextual oncogene or tumor suppressor? Cancer research \n                           73, 2929\u20132935, doi:10.1158\/0008-5472.CAN-12-3876 (2013).","journal-title":"Cancer research"},{"key":"6149_CR60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/BJ20131344","volume":"459","author":"SA Hawley","year":"2014","unstructured":"Hawley, S. A. et al. Phosphorylation by Akt within the ST loop of AMPK-alpha1 down-regulates its activation in tumour cells. The Biochemical journal \n                           459, 275\u2013287, doi:10.1042\/BJ20131344 (2014).","journal-title":"The Biochemical journal"},{"key":"6149_CR61","doi-asserted-by":"publisher","first-page":"e48208","DOI":"10.1371\/journal.pone.0048208","volume":"7","author":"S Pathi","year":"2012","unstructured":"Pathi, S. et al. Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors. PloS one \n                           7, e48208, doi:10.1371\/journal.pone.0048208 (2012).","journal-title":"PloS one"},{"key":"6149_CR62","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/carcin\/bgt340","volume":"35","author":"EH Nam","year":"2014","unstructured":"Nam, E. H. et al. ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin alpha5 expression. Carcinogenesis \n                           35, 302\u2013314, doi:10.1093\/carcin\/bgt340 (2014).","journal-title":"Carcinogenesis"},{"key":"6149_CR63","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1124\/mol.112.079020","volume":"82","author":"A Omanakuttan","year":"2012","unstructured":"Omanakuttan, A. et al. Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9. Molecular pharmacology \n                           82, 614\u2013622, doi:10.1124\/mol.112.079020 (2012).","journal-title":"Molecular pharmacology"},{"key":"6149_CR64","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nature reviews. Molecular cell biology \n                           15, 178\u2013196, doi:10.1038\/nrm3758 (2014).","journal-title":"Nature reviews. Molecular cell biology"},{"key":"6149_CR65","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1091\/mbc.E16-04-0249","volume":"27","author":"PM Pifer","year":"2016","unstructured":"Pifer, P. M. et al. Grainyhead-like 2 inhibits the coactivator p300, suppressing tubulogenesis and the epithelial-mesenchymal transition. Molecular biology of the cell \n                           27, 2479\u20132492, doi:10.1091\/mbc.E16-04-0249 (2016).","journal-title":"Molecular biology of the cell"},{"key":"6149_CR66","doi-asserted-by":"publisher","unstructured":"Farria, A., Li, W. & Dent, S. Y. KATs in cancer: functions and therapies. Oncogene, doi:10.1038\/onc.2014.453 (2015).","DOI":"10.1038\/onc.2014.453"},{"key":"6149_CR67","doi-asserted-by":"publisher","first-page":"W71","DOI":"10.1093\/nar\/gkm306","volume":"35","author":"A Untergasser","year":"2007","unstructured":"Untergasser, A. et al. Primer3Plus, an enhanced web interface to Primer3. Nucleic acids research \n                           35, W71\u201374, doi:10.1093\/nar\/gkm306 (2007).","journal-title":"Nucleic acids research"},{"key":"6149_CR68","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nature methods \n                           9, 671\u2013675 (2012).","journal-title":"Nature methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06149-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06149-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06149-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:56:06Z","timestamp":1671778566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06149-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6149"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06149-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,17]]},"assertion":[{"value":"28 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5626"}}